Good results? Maybe, BUT the results don't indicate what is the best dosage to use yet. 2x/wk for pain relief and function improvement OR 1x/wk for OA disease modification? They still need to try and work out why Zilusol has different outcomes with different dosages and doesn't work for some patients and does for others, if they are going to justify $6k+ for 12 doses. There are still many unanswered questions which the FDA will need explanations for before deciding the dosage for Phase III trial next year.
Ann: Change of Director's Interest Notice - Fisher, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.015(5.88%) |
Mkt cap ! $84.05M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.5¢ | 24.0¢ | $167.2K | 671.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 108741 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 9700 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |